These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Evaluation of exercise capacity with cardiopulmonary exercise test and B-type natriuretic peptide in adults with congenital heart disease. Trojnarska O; Gwizdała A; Katarzyński S; Katarzyńska A; Szyszka A; Lanocha M; Grajek S; Kramer L Cardiol J; 2009; 16(2):133-41. PubMed ID: 19387960 [TBL] [Abstract][Full Text] [Related]
24. [Pulmonary arterial hypertension. Part I: pathobiologic, pathophysiologic, clinical and diagnostic aspects]. Palazzini M; Manes A; Negro L; Marinelli A; Leci E; Gambetti S; Bachetti C; Beciani E; Conficoni E; Branzi A; Galiè N G Ital Cardiol (Rome); 2009 May; 10(5):271-300. PubMed ID: 19537440 [TBL] [Abstract][Full Text] [Related]
25. [Current recommendations for the diagnosis and treatment of pulmonary hypertension]. Olschewski H Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S334-7. PubMed ID: 17139601 [TBL] [Abstract][Full Text] [Related]
26. [The role of cardiopulmonary exercise testing in the assessment of pulmonary hypertension]. Dumitrescu D; Rosenkranz S Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S176-9. PubMed ID: 18814090 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases. Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103 [TBL] [Abstract][Full Text] [Related]
28. [Novel concepts in the pathobiology of pulmonary arterial hypertension]. Rosenkranz S Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S167-9. PubMed ID: 18814087 [TBL] [Abstract][Full Text] [Related]
30. Pulmonary arterial hypertension in congenital cardiac disease--the need for refinement of the Evian-Venice classification. van Albada ME; Berger RM Cardiol Young; 2008 Feb; 18(1):10-7. PubMed ID: 18205971 [TBL] [Abstract][Full Text] [Related]
31. The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis. Mirsaeidi M; Omar HR; Baughman R; Machado R; Sweiss N Sarcoidosis Vasc Diffuse Lung Dis; 2016 Dec; 33(4):317-320. PubMed ID: 28079843 [TBL] [Abstract][Full Text] [Related]
32. N-terminal brain natriuretic peptide as a diagnostic test in cirrhotic patients with pulmonary arterial hypertension. Bernal V; Pascual I; Esquivias P; García-Gil A; Mateo JM; Lacambra I; Serrano MT; Simón MA Transplant Proc; 2009 Apr; 41(3):987-8. PubMed ID: 19376405 [TBL] [Abstract][Full Text] [Related]
33. [Pulmonary hypertension in COPD and interstitial lung diseases]. Markart P; Ghofrani HA; Grimminger F; Günther A Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606 [TBL] [Abstract][Full Text] [Related]
34. [Usefulness of B-type natriuretic peptide (BNP) for the diagnosis of new-onset heart failure with a preserved left ventricular systolic function in longstanding hypertensive patients with acute dyspnea]. Arquès S; Roux E; Sbragia P; Pieri B; Gélisse R; Luccioni R; Ambrosi P Arch Mal Coeur Vaiss; 2007 Feb; 100(2):113-20. PubMed ID: 17474496 [TBL] [Abstract][Full Text] [Related]
35. Pulmonary hypertension in the critical care setting: classification, pathophysiology, diagnosis, and management. Rubenfire M; Bayram M; Hector-Word Z Crit Care Clin; 2007 Oct; 23(4):801-34, vi-vii. PubMed ID: 17964364 [TBL] [Abstract][Full Text] [Related]
36. N-terminal-pro-B type natriuretic peptide as a useful tool to evaluate pulmonary hypertension and cardiac function in CDH infants. Baptista MJ; Rocha G; Clemente F; Azevedo LF; Tibboel D; Leite-Moreira AF; Guimarães H; Areias JC; Correia-Pinto J Neonatology; 2008; 94(1):22-30. PubMed ID: 18160811 [TBL] [Abstract][Full Text] [Related]